F. Lesperance, N. Frasure-smith, and M. Talajic, Major depression before and after myocardial infarction: its nature and consequences, Psychosom Med, vol.58, pp.99-110, 1996.

S. J. Schleifer, M. M. Macari-hinson, D. A. Coyle, W. R. Slater, M. Kahn et al., The nature and course of depression following myocardial infarction, Arch Intern Med, vol.149, pp.1785-1794, 1989.

J. P. Van-melle, P. De-jonge, T. A. Spijkerman, J. G. Tijssen, J. Ormel et al., Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis, Psychosom Med, vol.66, pp.814-836, 2004.

N. Frasure-smith, F. Lesperance, and M. Talajic, Depression following myocardial infarction. Impact on 6-month survival, JAMA, vol.270, pp.1819-1844, 1993.

S. Parashar, J. S. Rumsfeld, J. A. Spertus, K. J. Reid, N. K. Wenger et al., Time course of depression and outcome of myocardial infarction, Arch Intern Med, vol.166, pp.2035-2078, 2006.

V. Vaccarino, B. D. Johnson, D. S. Sheps, S. E. Reis, S. F. Kelsey et al., Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study, J Am Coll Cardiol, vol.50, pp.2044-50, 2007.

N. Frasure-smith, F. Lesperance, G. Gravel, A. Masson, M. Juneau et al., Social support, depression, and mortality during the first year after myocardial infarction, Circulation, vol.101, pp.1919-1943, 2000.

F. Lesperance, N. Frasure-smith, M. Talajic, and M. G. Bourassa, Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction, Circulation, vol.105, pp.1049-53, 2002.

N. Frasure-smith, F. Lesperance, M. Habra, M. Talajic, P. Khairy et al., Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure, Circulation, vol.120, pp.134-174, 2009.

P. Libby and P. Theroux, Pathophysiology of coronary artery disease, Circulation, vol.111, pp.3481-3489, 2005.

P. M. Ridker, C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus, J Am Coll Cardiol, vol.49, pp.2129-2167, 2007.

M. Danner, S. V. Kasl, J. L. Abramson, and V. Vaccarino, Association between depression and elevated C-reactive protein, Psychosom Med, vol.65, pp.347-56, 2003.

J. P. Empana, D. H. Sykes, G. Luc, I. Juhan-vague, D. Arveiler et al., Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME), Circulation, vol.111, pp.2299-305, 2005.

M. Berk, A. A. Wadee, R. H. Kuschke, O. Neill-kerr, and A. , Acute phase proteins in major depression, J Psychosom Res, vol.43, pp.529-563, 1997.

G. E. Miller, C. A. Stetler, R. M. Carney, K. E. Freedland, and W. A. Banks, Clinical depression and inflammatory risk markers for coronary heart disease, Am J Cardiol, vol.90, pp.1279-83, 2002.

L. Capuron, A. Ravaud, P. J. Neveu, A. H. Miller, M. Maes et al., Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy, Mol Psychiatry, vol.7, pp.468-73, 2002.

C. L. Raison, L. Capuron, and A. H. Miller, Cytokines sing the blues: inflammation and the pathogenesis of depression, Trends Immunol, vol.27, pp.24-31, 2006.

R. Dantzer, J. C. O'connor, G. G. Freund, R. W. Johnson, and K. W. Kelley, From inflammation to sickness and depression: when the immune system subjugates the brain, Nat Rev, vol.9, pp.46-56, 2008.

M. Riedel, M. Lafitte, Y. Pucheu, K. Latry, and T. Couffinhal, Prognostic value of high-sensitivity C-reactive protein in a population of post-acute coronary syndrome patients receiving optimal medical treatment, Eur J Prev Cardiol, vol.19, pp.1128-1165, 2012.

E. M. Antman, M. Hand, P. W. Armstrong, E. R. Bates, L. A. Green et al., Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology, American Heart Association Task Force on Practice Guidelines. Circulation, vol.117, pp.296-329, 2007.

D. V. Sheehan, Y. Lecrubier, K. H. Sheehan, P. Amorim, J. Janavs et al., The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10, J Clin Psychiatry, vol.59, pp.34-57, 1998.

K. Demyttenaere, D. Fruyt, and J. , Getting what you ask for: on the selectivity of depression rating scales, Psychother Psychosom, vol.72, pp.61-70, 2003.

M. Lafitte, Y. Pucheu, K. Latry, M. Dijos, E. Casassus et al., Predictors of cardiovascular prognosis in patients receiving optimized secondary prevention measures after acute coronary syndrome, Eur J Prev Cardiol, vol.20, pp.283-90, 2013.

B. D. Thombs, E. B. Bass, D. E. Ford, K. J. Stewart, K. K. Tsilidis et al., Prevalence of depression in survivors of acute myocardial infarction, J Gen Intern Med, vol.21, pp.30-38, 2006.

B. D. Thombs, P. De-jonge, J. C. Coyne, M. A. Whooley, N. Frasure-smith et al., Depression screening and patient outcomes in cardiovascular care: a systematic review, JAMA, vol.300, pp.2161-71, 2008.

B. D. Thombs, E. Arthurs, G. El-baalbaki, A. Meijer, R. C. Ziegelstein et al., Risk of bias from inclusion of patients who already have diagnosis of or are undergoing treatment for depression in diagnostic accuracy studies of screening tools for depression: systematic review, BMJ, vol.343, p.4825, 2011.

L. Poole, C. Dickens, and A. Steptoe, The puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation, J Psychosom Res, vol.71, pp.61-69, 2011.

M. B. Howren, D. M. Lamkin, and J. Suls, Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis, Psychosom Med, vol.71, pp.171-86, 2009.

D. Gimeno, M. Kivimaki, E. J. Brunner, M. Elovainio, D. Vogli et al., Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study, Psychol Med, vol.39, pp.413-436, 2009.

N. Frasure-smith, F. Lesperance, M. R. Irwin, M. Talajic, and B. G. Pollock, The relationships among heart rate variability, inflammatory markers and depression in coronary heart disease patients, Brain Behav Immun, vol.23, pp.1140-1147, 2009.

N. Frasure-smith, F. Lesperance, M. R. Irwin, C. Sauve, J. Lesperance et al., Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes, Biol Psychiatry, vol.62, pp.302-310, 2007.

F. Lesperance, N. Frasure-smith, P. Theroux, and M. Irwin, The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes, Am J Psychiatry, vol.161, pp.271-278, 2004.

L. Capuron, A. Ravaud, N. Gualde, E. Bosmans, R. Dantzer et al., Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy, Psychoneuroendocrinology, vol.26, pp.797-808, 2001.

L. Capuron and A. H. Miller, Cytokines and psychopathology: lessons from interferon-alpha, Biol Psychiatry, vol.56, pp.819-843, 2004.

J. J. Strik, A. Honig, R. Lousberg, and J. Denollet, Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction, Psychosomatics, vol.42, pp.423-431, 2001.

C. Otte, S. Zhao, and M. A. Whooley, Statin use and risk of depression in patients with coronary heart disease: longitudinal data from the heart and soul study, J Clin Psychiatry, vol.73, pp.610-615, 2012.

J. Bonnet, R. Mcpherson, A. Tedgui, D. Simoneau, A. Nozza et al., Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study, Clin Ther, vol.30, pp.2298-313, 2008.

J. H. Lichtman, J. T. Bigger, J. A. Blumenthal, N. Frasure-smith, P. G. Kaufmann et al., Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association, Circulation, vol.118, pp.1768-75, 2008.

R. C. Ziegelstein, B. D. Thombs, J. C. Coyne, and P. De-jonge, Routine screening for depression in patients with coronary heart disease never mind, J Am Coll Cardiol, vol.54, pp.886-90, 2009.

, National Institute for Health and Clinical Excellence: Guidance. National Collaborating Centre for Mental Health (UK).: Depression: The Treatment and Management of Depression in Adults, 2010.